Literature DB >> 1756516

Inhibitory effects of Ixora javanica extract on skin chemical carcinogenesis in mice and its antitumour activity.

S C Nair1, B Panikkar, K G Akamanchi, K R Panikkar.   

Abstract

Topical application of 100 mg/kg body weight of Ixora javanica flower extract inhibited the growth and delayed the onset of papilloma formation in mice initiated with 7,12-dimethylbenz[a]anthracene (DMBA) and promoted using croton oil. The extract at the same dose, when administered orally inhibited the growth of subcutaneously injected 20-methylcholanthrene (MCA)-induced soft tissue fibrosarcomas significantly. Oral administration of 200 mg/kg of the extract inhibited the growth of intraperitoneally transplanted sarcoma-180 and Ehrlich ascites carcinoma tumours besides showing an increase in the life span of the treated mice. Toxicity studies showed that the blood urea nitrogen levels were elevated post treatment. The active compounds responsible for the above inhibitory effects on tumour growth were identified as ferulic acid (4-hydroxy-3-methoxy cinnamic acid) and its regionmer 3-hydroxy-4-methoxy cinnamic acid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756516     DOI: 10.1016/0304-3835(91)90121-w

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Anti-tumor and antioxidant activity of kaempferol-3-O-alpha-L-rhamnoside (Afzelin) isolated from Pithecellobium dulce leaves.

Authors:  Masuma Akter; Mst Shahnaj Parvin; Md Mahadi Hasan; Md Aziz Abdur Rahman; Md Ekramul Islam
Journal:  BMC Complement Med Ther       Date:  2022-06-22

2.  Application and optimization of ultrasound-assisted deep eutectic solvent for the extraction of new skin-lightening cosmetic materials from Ixora javanica flower.

Authors:  Nina Dewi Oktaviyanti; Abdul Mun'im
Journal:  Heliyon       Date:  2019-11-30

Review 3.  The Impact of Javanica Oil Emulsion Injection on Chemotherapy Efficacy and Cellular Immune Indicators in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis.

Authors:  Huilin Xu; Zhucheng Yin; Anbing He; Dedong Cao
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-22       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.